Antibiotic resistance mechanisms of Vibrio cholerae

Journal of Medical Microbiology

Volumn 60, Issue 4, 2011, Pages 397-407

  Kitaoka, Maya ^a   Miyata, Sarah T ^a   Unterweger, Daniel ^a   Pukatzki, Stefan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALAFOSFALIN; AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; DOXORUBICIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; LINEZOLID; NALIDIXIC ACID; NORFLOXACIN; PENICILLIN G; POLYMYXIN B; QUINOLONE; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CHOLERA; CHROMOSOME MUTATION; DEHYDRATION; EFFUSION; HUMAN; PLASMID; PRIORITY JOURNAL; PROTON MOTIVE FORCE; PUBLIC HEALTH PROBLEM; REVIEW; SPONTANEOUS MUTATION; VIBRIO CHOLERAE;

ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; DRUG RESISTANCE, BACTERIAL; HUMANS; INTEGRONS; MUTATION; PLASMIDS; VIBRIO CHOLERAE;

EID: 79953005566     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.023051-0     Document Type: Review

References (109)

1. Abera, B., Bezabih, B. & Dessie, A. (2010). Antimicrobial susceptibility of V. cholerae in north west, Ethiopia. Ethiop Med J 48, 23-28.
2. Adabi, M., Bakhshi, B., Goudarzi, H., Zahraei, S. M. & Pourshafie, M. R. (2009). Distribution of class I integron and sulfamethoxazole trimethoprim constin in Vibrio cholerae isolated from patients in Iran. Microb Drug Resist 15, 179-184.
3. Allen, J. G., Atherton, F. R., Hall, M. J., Hassall, C. H., Holmes, S. W., Lambert, R. W., Nisbet, L. J. & Ringrose, P. S. (1979). Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides. Antimicrob Agents Chemother 15, 684-695. (Pubitemid 9160347)
4. Atherton, F. R., Hall, M. J., Hassall, C. H., Lambert, R. W., Lloyd, W. J. & Ringrose, P. S. (1979). Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin. Antimicrob Agents Chemother 15, 696-705. (Pubitemid 9160348)
5. Bani, S., Mastromarino, P. N., Ceccarelli, D., Le Van, A., Salvia, A. M., Ngo Viet, Q. T., Hai, D. H., Bacciu, D., Cappuccinelli, P. & Colombo, M. M. (2007). Molecular characterization of ICEVchVie0 and its disappearance in Vibrio cholerae O1 strains isolated in 2003 in Vietnam. FEMS Microbiol Lett 266, 42-48. (Pubitemid 44924309)
6. Baranwal, S., Dey, K., Ramamurthy, T., Nair, G. B. & Kundu, M. (2002). Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae. Antimicrob Agents Chemother 46, 2676-2678. (Pubitemid 34793486)
7. Beaber, J. W., Hochhut, B. & Waldor, M. K. (2004). SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427, 72-74. (Pubitemid 38094823)
8. Begum, A., Rahman, M. M., Ogawa, W., Mizushima, T., Kuroda, T. & Tsuchiya, T. (2005). Gene cloning and characterization of four MATE family multidrug efflux pumps from Vibrio cholerae non-O1. Microbiol Immunol 49, 949-957. (Pubitemid 41687168)
9. Bina, J. E., Provenzano, D., Wang, C., Bina, X. R. & Mekalanos, J. J. (2006). Characterization of the Vibrio cholerae vexAB and vexCD efflux systems. Arch Microbiol 186, 171-181. (Pubitemid 44273093)
10. Bina, X. R., Provenzano, D., Nguyen, N. & Bina, J. E. (2008). Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. Infect Immun 76, 3595-3605.
11. Binsztein, N., Costagliola, M. C., Pichel, M., Jurquiza, V., Ramírez, F. C., Akselman, R., Vacchino, M., Huq, A. & Colwell, R. (2004). Viable but nonculturable Vibrio cholerae O1 in the aquatic environment of Argentina. Appl Environ Microbiol 70, 7481-7486. (Pubitemid 39643815)
12. Burrus, V. & Waldor, M. K. (2003). Control of SXT integration and excision. J Bacteriol 185, 5045-5054. (Pubitemid 37021966)
13. Burrus, V., Marrero, J. & Waldor, M. K. (2006). The current ICE age: biology and evolution of SXT-related integrating conjugative elements. Plasmid 55, 173-183.
14. Cash, R. A., Music, S. I., Libonati, J. P., Snyder, M. J., Wenzel, R. P. & Hornick, R. B. (1974). Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis 129, 45-52.
15. Chander, J., Kaistha, N., Gupta, V., Mehta, M., Singla, N., Deep, A. & Sarkar, B. L. (2009). Epidemiology & antibiograms of Vibrio cholerae isolates from a tertiary care hospital in Chandigarh, north India. Indian J Med Res 129, 613-617.
16. Chandrasekhar, M. R., Krishna, B. V. & Patil, A. B. (2008). Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups. Southeast Asian J Trop Med Public Health 39, 1092-1097.
17. Clatworthy, A. E., Pierson, E. & Hung, D. T. (2007). Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol 3, 541-548. (Pubitemid 47294400)
18. Colmer, J. A., Fralick, J. A. & Hamood, A. N. (1998). Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae. Mol Microbiol 27, 63-72. (Pubitemid 28022577)
19. Colwell, R. R. (1996). Global climate and infectious disease: the cholera paradigm. Science 274, 2025-2031.
20. Daccord, A., Ceccarelli, D. & Burrus, V. (2010). Integrating conjugative elements of the SXT/R391 family trigger the excision and drive the mobilization of a new class of Vibrio genomic islands. Mol Microbiol 78, 576-588.
21. Dalsgaard, A., Forslund, A., Tam, N. V., Vinh, D. X. & Cam, P. D. (1999). Cholera in Vietnam: changes in genotypes and emergence of class I integrons containing aminoglycoside resistance gene cassettes in Vibrio cholerae O1 strains isolated from 1979 to 1996. J Clin Microbiol 37, 734-741. (Pubitemid 29091294)
22. Das, S., Saha, R. & Kaur, I. R. (2008). Trend of antibiotic resistance of Vibrio cholerae strains from East Delhi. Indian J Med Res 127, 478-482.
23. Dizon, J. J., Fukumi, H., Barua, D., Valera, J., Jayme, F., Gomez, F., Yamamoto, S. I., Wake, A., Gomez, C. Z. & other authors (1967). Studies on cholera carriers. Bull World Health Organ 37, 737-743.
24. Ehara, M., Nguyen, B. M., Nguyen, D. T., Toma, C., Higa, N. & Iwanaga, M. (2004). Drug susceptibility and its genetic basis in epidemic Vibrio cholerae O1 in Vietnam. Epidemiol Infect 132, 595-600. (Pubitemid 39140090)
25. Ewald, P. W. (1994). Evolution of Infectious Disease. Oxford: Oxford University Press.
26. Faruque, S. M., Albert, M. J. & Mekalanos, J. J. (1998). Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev 62, 1301-1314. (Pubitemid 28558300)
27. Faruque, S. M., Islam, M. J., Ahmad, Q. S., Faruque, A. S., Sack, D. A., Nair, G. B. & Mekalanos, J. J. (2005). Self-limiting nature of seasonal cholera epidemics: role of host-mediated amplification of phage. Proc Natl Acad Sci U S A 102, 6119-6124. (Pubitemid 40594265)
28. Faruque, S. M., Islam, M. J., Ahmad, Q. S., Biswas, K., Faruque, A. S., Nair, G. B., Sack, R. B., Sack, D. A. & Mekalanos, J. J. (2006). An improved technique for isolation of environmental Vibrio cholerae with epidemic potential: monitoring the emergence of a multiple-antibiotic-resistant epidemic strain in Bangladesh. J Infect Dis 193, 1029-1036.
29. Faruque, A. S., Alam, K., Malek, M. A., Khan, M. G., Ahmed, S., Saha, D., Khan, W. A., Nair, G. B., Salam, M. A. & other authors (2007). Emergence of multidrug-resistant strain of Vibrio cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after two years. J Health Popul Nutr 25, 241-243.
30. Garg, P., Sinha, S., Chakraborty, R., Bhattacharya, S. K., Nair, G. B., Ramamurthy, T. & Takeda, Y. (2001). Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India. Antimicrob Agents Chemother 45, 1605-1606.
31. Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T. & Tomizawa, J. I. (1977). Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci U S A 74, 4772-4776. (Pubitemid 8227005)
32. Glass, R. I., Huq, I., Alim, A. R. & Yunus, M. (1980). Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh. J Infect Dis 142, 939-942. (Pubitemid 11153263)
33. Glass, R. I., Huq, M. I., Lee, J. V., Threlfall, E. J., Khan, M. R., Alim, A. R., Rowe, B. & Gross, R. J. (1983). Plasmid-borne multiple drug resistance in Vibrio cholerae serogroup O1, biotype El Tor: evidence for a point-source outbreak in Bangladesh. J Infect Dis 147, 204-209.
34. Goel, A. K., Jain, M., Kumar, P. & Jiang, S. C. (2010). Molecular characterization of Vibrio cholerae outbreak strains with altered El Tor biotype from southern India. World J Microbiol Biotechnol 26, 281-287.
35. Goss, W. A., Deitz, W. H. & Cook, T. M. (1965). Mechanism of action of nalidixic acid on Escherichia coli. Inhibition of deoxyribonucleic acid synthesis. J Bacteriol 89, 1068-1074.
36. Greenough, W. B., III, Gordon, R. S., Jr, Rosenberg, I. S., Davies, B. I. & Benenson, A. S. (1964). Tetracycline in the treatment of cholera. Lancet 1, 355-357.
37. Guerin, E., Cambray, G., Sanchez-Alberola, N., Campoy, S., Erill, I., Da Re, S., Gonzalez-Zorn, B., Barbé, J., Ploy, M. C. & Mazel, D. (2009). The SOS response controls integron recombination. Science 324, 1034.
38. Hedges, R. W. & Jacob, A. E. (1975). A 98 megadalton R factor of compatibility group C in a Vibrio cholerae El Tor isolate from southern U.S.S.R. J Gen Microbiol 89, 383-386.
39. Heidelberg, J. F., Eisen, J. A., Nelson, W. C., Clayton, R. A., Gwinn, M. L., Dodson, R. J., Haft, D. H., Hickey, E. K., Peterson, J. D. & other authors (2000). DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406, 477-483. (Pubitemid 30625724)
40. Herrington, D. A., Hall, R. H., Losonsky, G., Mekalanos, J. J., Taylor, R. K. & Levine, M. M. (1988). Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med 168, 1487-1492. (Pubitemid 18264881)
41. Hochhut, B. & Waldor, M. K. (1999). Site-specific integration of the conjugal Vibrio cholerae SXT element into prfC. Mol Microbiol 32, 99-110. (Pubitemid 29164137)
42. Hochhut, B., Marrero, J. & Waldor, M. K. (2000). Mobilization of plasmids and chromosomal DNA mediated by the SXT element, a constin found in Vibrio cholerae O139. J Bacteriol 182, 2043-2047. (Pubitemid 30165397)
43. Hochhut, B., Lotfi, Y., Mazel, D., Faruque, S. M., Woodgate, R. & Waldor, M. K. (2001). Molecular analysis of antibiotic resistance gene clusters in Vibrio cholerae O139 and O1 SXT constins. Antimicrob Agents Chemother 45, 2991-3000. (Pubitemid 32988819)
44. Huda, M. N., Chen, J., Morita, Y., Kuroda, T., Mizushima, T. & Tsuchiya, T. (2003). Gene cloning and characterization of VcrM, a Na+-coupled multidrug efflux pump, from Vibrio cholerae non-O1. Microbiol Immunol 47, 419-427. (Pubitemid 36759447)
45. Hung, D. T., Shakhnovich, E. A., Pierson, E. & Mekalanos, J. J. (2005). Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310, 670-674. (Pubitemid 41528158)
46. Huq, A., Small, E. B., West, P. A., Huq, M. I., Rahman, R. & Colwell, R. R. (1983). Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol 45, 275-283. (Pubitemid 13175306)
47. Islam, A., Bardhan, P. K., Islam, M. R. & Rahman, M. (1986). A randomized double blind trial of aspirin versus placebo in cholera and non-cholera diarrhoea. Trop Geogr Med 38, 221-225. (Pubitemid 16009260)
48. Islam, M. S., Midzi, S. M., Charimari, L., Cravioto, A. & Endtz, H. P. (2009). Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrheal patients in Zimbabwe. JAMA 302, 2321-2322.
49. Iwanaga, M., Toma, C., Miyazato, T., Insisiengmay, S., Nakasone, N. & Ehara, M. (2004). Antibiotic resistance conferred by a class I integron and SXT constin in Vibrio cholerae O1 strains isolated in Laos. Antimicrob Agents Chemother 48, 2364-2369. (Pubitemid 38823398)
50. Jabeen, K., Zafar, A. & Hasan, R. (2008). Increased isolation of Vibrio cholerae O1 serotype Inaba over serotype Ogawa in Pakistan. East Mediterr Health J 14, 564-570.
51. Jain, M., Kumar, P., Goel, A. K., Kamboj, D. V. & Singh, L. (2008). Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India. Int J Antimicrob Agents 32, 459-460.
52. Kaper, J., Lockman, H., Colwell, R. R. & Joseph, S. W. (1979). Ecology, serology, and enterotoxin production of Vibrio cholerae in Chesapeake Bay. Appl Environ Microbiol 37, 91-103.
53. Karki, R., Bhatta, D. R., Malla, S. & Dumre, S. P. (2010). Cholera incidence among patients with diarrhea visiting National Public Health Laboratory, Nepal. Jpn J Infect Dis 63, 185-187.
54. Katzung, B. G., Masters, S. B. & Trevor, A. J. (2009). Basic & Clinical Pharmacology, 11th edn. New York and London: McGraw-Hill.
55. Keramat, F., Hashemi, S. H., Mamani, M., Ranjbar, M. & Erfan, H. (2008). Survey of antibiogram tests in cholera patients in the 2005 epidemic in Hamadan, Islamic Republic of Iran. East Mediterr Health J 14, 768-775.
56. Kim, H. B., Wang, M., Ahmed, S., Park, C. H., LaRocque, R. C., Faruque, A. S., Salam, M. A., Khan, W. A., Qadri, F. & other authors (2010). Transferable quinolone resistance in Vibrio cholerae. Antimicrob Agents Chemother 54, 799-803.
57. Kirn, T. J., Lafferty, M. J., Sandoe, C. M. & Taylor, R. K. (2000). Delineation of pilin domains required for bacterial association into microcolonies and intestinal colonization by Vibrio cholerae. Mol Microbiol 35, 896-910. (Pubitemid 30107540)
58. Krishna, B. V., Patil, A. B. & Chandrasekhar, M. R. (2006). Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India. Trans R Soc Trop Med Hyg 100, 224-226. (Pubitemid 43091819)
59. Lindenbaum, J., Greenough, W. B. & Islam, M. R. (1967). Antibiotic therapy of cholera. Bull World Health Organ 36, 871-883.
60. MacIntyre, D. L., Miyata, S. T., Kitaoka, M. & Pukatzki, S. (2010). The Vibrio cholerae type VI secretion system displays antimicrobial properties. Proc Natl Acad Sci U S A 107, 19520-19524.
61. Maier, R. A. & Pepper, I. L. (2009). Environmental Microbiology, 2nd edn. Amsterdam and London: Elsevier Academic Press.
62. Mandomando, I., Espasa, M., Vallès, X., Sacarlal, J., Sigaúque, B., Ruiz, J. & Alonso, P. (2007). Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhiça District Hospital, southern Mozambique. J Antimicrob Chemother 60, 662-664. (Pubitemid 47299886)
63. Manga, N. M., Ndour, C. T., Diop, S. A., Dia, N. M., Ka-Sall, R., Diop, B. M., Sow, A. I. & Sow, P. S. (2008). Cholera in Senegal from 2004 to 2006: lessons learned from successive outbreaks. Med Trop (Mars) 68, 589-592.
64. Martínez, J. L. (2008). Antibiotics and antibiotic resistance genes in natural environments. Science 321, 365-367.
65. Mazel, D. (2006). Integrons: agents of bacterial evolution. Nat Rev Microbiol 4, 608-620.
66. Mekalanos, J. J., Rubin, E. J. & Waldor, M. K. (1997). Cholera: molecular basis for emergence and pathogenesis. FEMS Immunol Med Microbiol 18, 241-248. (Pubitemid 27397496)
67. Mhalu, F. S., Mmari, P. W. & Ijumba, J. (1979). Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Lancet 1, 345-347. (Pubitemid 9109485)
68. Molla, A. M., Gyr, K., Bardhan, P. K. & Molla, A. (1984). Effect of intravenous somatostatin on stool output in diarrhea due to Vibrio cholerae. Gastroenterology 87, 845-847. (Pubitemid 14040456)
69. Morita, Y., Kodama, K., Shiota, S., Mine, T., Kataoka, A., Mizushima, T. & Tsuchiya, T. (1998). NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob Agents Chemother 42, 1778-1782. (Pubitemid 28311578)
70. Ngandjio, A., Tejiokem, M., Wouafo, M., Ndome, I., Yonga, M., Guenole, A., Lemee, L., Quilici, M. L. & Fonkoua, M. C. (2009). Antimicrobial resistance and molecular characterization of Vibrio cholerae O1 during the 2004 and 2005 outbreak of cholera in Cameroon. Foodborne Pathog Dis 6, 49-56.
71. Opintan, J. A., Newman, M. J., Nsiah-Poodoh, O. A. & Okeke, I. N. (2008). Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element. J Antimicrob Chemother 62, 929-933.
72. Pan, J. C., Ye, R., Wang, H. Q., Xiang, H. Q., Zhang, W., Yu, X. F., Meng, D. M. & He, Z. S. (2008). Vibrio cholerae O139 multiple-drug resistance mediated by Yersinia pestis pIP1202-like conjugative plasmids. Antimicrob Agents Chemother 52, 3829-3836.
73. Paulsen, I. T., Brown, M. H. & Skurray, R. A. (1996). Proton-dependent multidrug efflux systems. Microbiol Rev 60, 575-608. (Pubitemid 26415669)
74. Pierce, N. F., Banwell, J. G., Mitra, R. C., Caranasos, G. J., Keimowitz, R. I., Thomas, J. & Mondal, A. (1968). Controlled comparison of tetracycline and furazolidone in cholera. BMJ 3, 277-280.
75. Provenzano, D., Kovác, P. & Wade, W. F. (2006). The ABCs (Antibody, B cells, and Carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine. Microbiol Immunol 50, 899-927. (Pubitemid 44974647)
76. Putman, M., van Veen, H. W. & Konings, W. N. (2000). Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev 64, 672-693. (Pubitemid 32475926)
77. Rabbani, G. H., Butler, T., Bardhan, P. K. & Islam, A. (1983). Reduction of fluid-loss in cholera by nicotinic acid: a randomised controlled trial. Lancet 2, 1439-1442.
78. Rabbani, G. H., Butler, T., Knight, J., Sanyal, S. C. & Alam, K. (1987). Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis 155, 979-984. (Pubitemid 17062836)
79. Rabbani, G. H., Butler, T., Patte, D. & Abud, R. L. (1989). Clinical trial of clonidine hydrochloride as an antisecretory agent in cholera. Gastroenterology 97, 321-325. (Pubitemid 19192167)
80. Rakoto Alson, A. O., Dromigny, J. A., Pfister, P. & Mauclère, P. (2001). Vibrio cholerae in Madagascar: study of a multiresistant strain. Arch Inst Pasteur Madagascar 67, 6-13.
81. Ranjbar, M., Rahmani, E., Nooriamiri, A., Gholami, H., Golmohamadi, A., Barati, H., Rajabifar, D., Barati, S., Sabet, M. S. & other authors (2010). High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008. Trop Doct 40, 214-216.
82. Reidl, J. & Klose, K. E. (2002). Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol Rev 26, 125-139. (Pubitemid 34634084)
83. Roy, S. K., Islam, A., Ali, R., Islam, K. E., Khan, R. A., Ara, S. H., Saifuddin, N. M. & Fuchs, G. J. (1998). A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children. Trans R Soc Trop Med Hyg 92, 460-462. (Pubitemid 28409905)
84. Roychowdhury, A., Pan, A., Dutta, D., Mukhopadhyay, A. K., Ramamurthy, T., Nandy, R. K., Bhattacharya, S. K. & Bhattacharya, M. K. (2008). Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India. Jpn J Infect Dis 61, 128-129. (Pubitemid 351663806)
85. Sack, D. A., Lyke, C., McLaughlin, C. & Suwanvanichkij, V. (2001). Antimicrobial resistance in shigellosis, cholera and campylobacteriosis. WHO Document WHO/CDS/CSR/DRS/2001.8. Geneva: World Health Organization.
86. Sack, D. A., Sack, R. B., Nair, G. B. & Siddique, A. K. (2004). Cholera. Lancet 363, 223-233. (Pubitemid 38114723)
87. Safa, A., Nair, G. B. & Kong, R. Y. (2010). Evolution of new variants of Vibrio cholerae O1. Trends Microbiol 18, 46-54.
88. Samal, B., Ghosh, S. K., Mohanty, S. K. & Patnaik, K. (2001). Epidemic of Vibrio cholerae serogroup O139 in Berhampur, Orissa. Indian J Med Res 114, 10-11. (Pubitemid 33103901)
89. Sedas, V. T. (2007). Influence of environmental factors on the presence of Vibrio cholerae in the marine environment: a climate link. J Infect Dev Ctries 1, 224-241.
90. Shimada, T., Arakawa, E., Itoh, K., Okitsu, T., Matsushima, A., Asai, Y., Yamai, S., Nakazato, T., Nair, G. B. & other authors (1994). Extended serotyping scheme for Vibrio cholerae. Curr Microbiol 28, 175-178. (Pubitemid 24081636)
91. Siddique, A. K., Akram, K., Zaman, K., Mutsuddy, P., Eusof, A. & Sack, R. B. (1996). Vibrio cholerae O139: how great is the threat of a pandemic? Trop Med Int Health 1, 393-398.
92. Singh, A. K., Haldar, R., Mandal, D. & Kundu, M. (2006). Analysis of the topology of Vibrio cholerae NorM and identification of amino acid residues involved in norfloxacin resistance. Antimicrob Agents Chemother 50, 3717-3723. (Pubitemid 44684886)
93. Smith, A. M., Keddy, K. H. & De Wee, L. (2008). Characterization of cholera outbreak isolates from Namibia, December 2006 to February 2007. Epidemiol Infect 136, 1207-1209.
94. Smith, K. P., Kumar, S. & Varela, M. F. (2009). Identification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395. Arch Microbiol 191, 903-911.
95. Sonawane, N. D., Hu, J., Muanprasat, C. & Verkman, A. S. (2006). Luminally active, nonabsorbable CFTR inhibitors as potential therapy to reduce intestinal fluid loss in cholera. FASEB J 20, 130-132. (Pubitemid 43100490)
96. Sugino, A., Peebles, C. L., Kreuzer, K. N. & Cozzarelli, N. R. (1977). Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci U S A 74, 4767-4771. (Pubitemid 8227004)
97. Summers, W. C. (1993). Cholera and plague in India: the bacteriophage inquiry of 1927-1936. J Hist Med Allied Sci 48, 275-301.
98. Taylor, R. K., Miller, V. L., Furlong, D. B. & Mekalanos, J. J. (1987). Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci U S A 84, 2833-2837.
99. Threlfall, E. J. & Rowe, B. (1982). Vibrio cholerae El Tor acquires plasmid-encoded resistance to gentamicin. Lancet 1, 42.
100. Tjaniadi, P., Lesmana, M., Subekti, D., Machpud, N., Komalarini, S., Santoso, W., Simanjuntak, C. H., Punjabi, N., Campbell, J. R. & other authors (2003). Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia. Am J Trop Med Hyg 68, 666-670.
101. Towner, K. J., Pearson, N. J., Mhalu, F. S. & O'Grady, F. (1980). Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania. Bull World Health Organ 58, 747-751.
102. Van Bambeke, F., Michot, J. M. & Tulkens, P. M. (2003). Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics. J Antimicrob Chemother 51, 1067-1077. (Pubitemid 36622060)
103. Van Loon, F. P., Rabbani, G. H., Bukhave, K. & Rask-Madsen, J. (1992). Indomethacin decreases jejunal fluid secretion in addition to luminal release of prostaglandin E2 in patients with acute cholera. Gut 33, 643-645.
104. Waldor, M. K., Tschäpe, H. & Mekalanos, J. J. (1996). A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J Bacteriol 178, 4157-4165. (Pubitemid 26240897)
105. WHO (1995). Meeting on the Potential Role of New Cholera Vaccines in the Prevention and Control of Cholera outbreaks during Acute Emergencies. Document CDR/GPV/95.1. Geneva: World Health Organization.
106. WHO (2002). New formula oral rehydration salts. WHO Drug Information 16, 121.
107. WHO (2004). Global Task Force on Cholera Control: first steps for managing an outbreak of acute diarrhoea. Document WHO-CDS-CSR-NCS-2003.7 Rev1. Geneva: World Health Organization.
108. WHO (2010). High hopes for oral cholera vaccine. Bull World Health Organ 88, 165-166.
109. Woolley, R. C., Vediyappan, G., Anderson, M., Lackey, M., Ramasubramanian, B., Jiangping, B., Borisova, T., Colmer, J. A., Hamood, A. N. & other authors (2005). Characterization of the Vibrio cholerae vceCAB multiple-drug resistance efflux operon in Escherichia coli. J Bacteriol 187, 5500-5503.